Seer, Inc. reported revenue of $3.1 million [1] for the second quarter ending June 30, 2026.

The financial results highlight the company's ability to maintain growth while navigating a tightening market for academic research grants. This balance is critical as the firm seeks to scale its proteomics platform amidst shifting funding priorities in the scientific community.

During a virtual conference call held Tuesday, Marissa Bych of the Gilmartin Group presented the company's quarterly performance. Management said that the revenue figure was achieved despite academic funding headwinds [2]. These headwinds refer to the reduced availability of grants and budgets typically used by university researchers to purchase high-end proteomics tools.

"Revenue grew to $3.1 million despite academic funding headwinds," Seer, Inc. management said [2].

The company's reporting period concluded on June 30, and the subsequent earnings call served as the primary venue for disclosing these financial metrics. The presentation focused on how the company is adapting its sales and operational strategies to mitigate the impact of the funding decline in the academic sector.

While the company reported growth, the reliance on academic institutions remains a point of focus for investors. The shift toward more diversified revenue streams, such as pharmaceutical partnerships, is often a key strategy for firms facing volatility in public research funding.

Marissa Bych opened the proceedings by welcoming participants to the Seer, Inc. Second Quarter 2026 Earnings Conference Call, she said [3].

Revenue grew to $3.1 million despite academic funding headwinds.

The growth in revenue despite academic funding headwinds suggests that Seer, Inc. may be successfully diversifying its client base or increasing the value of existing contracts. However, the explicit mention of funding challenges indicates that the academic market remains a volatile component of their business model, potentially making the company more dependent on corporate or private sector growth to sustain its trajectory.